Palatin Technologies (PTN) Receivables (2011 - 2025)
Palatin Technologies' (PTN) quarterly Receivables came in at $2.0 million in Q4 2025, down 71.33% quarter-over-quarter from $6.9 million in Q3 2025.
Analysis
Palatin Technologies (PTN) Receivables (2011 - 2025) Analysis & Trends
Palatin Technologies (PTN) has reported Receivables for 11 consecutive years, with $2.0 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Receivables changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $29468.0, changed N/A from the prior year.
- Receivables declined to $2.0 million in Q4 2025 per PTN's latest filing, from $6.9 million in the prior quarter.
- Across five years, Receivables topped out at $6.9 million in Q3 2025 and bottomed at $29468.0 in Q2 2025.
- Historically, Receivables has averaged $2.5 million across 4 years, with a median of $1.9 million in 2021.
- The sharpest annual moves came in 2021 and 2022: Receivables slumped 87.7% in 2021, then soared 1009.95% in 2022.
- Over 4 years, Receivables stood at $583991.0 in 2021, then jumped by 1009.95% to $6.5 million in 2022, then plunged by 63.8% to $2.3 million in 2023, then fell by 15.6% to $2.0 million in 2025.
- According to Business Quant data, Receivables over the past three periods registered $2.0 million, $6.9 million, and $29468.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.93 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 160.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 29,468.00 |
| Dec 31, 2023 | 2.35 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 2.92 Mn |
| Mar 31, 2023 | 6.37 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 790,005.00 |
| Dec 31, 2021 | 583,991.00 |
| Sep 30, 2021 | 914,015.00 |
| Jun 30, 2021 | 1.58 Mn |
| Mar 31, 2021 | 1.87 Mn |
| Dec 31, 2020 | 4.75 Mn |
| Sep 30, 2020 | 5.04 Mn |
| Jun 30, 2020 | 4.30 Mn |
| Dec 31, 2019 | 117,989.00 |
| Sep 30, 2019 | 97,379.00 |